| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 105.61% | Alliance Global Partners | $3.25 → $2.2 | Maintains | Buy |
| 03/28/2022 | — | Craig-Hallum | Downgrades | Buy → Hold | |
| 12/03/2021 | 437.38% | Alliance Global Partners | → $5.75 | Initiates Coverage On | → Buy |
| 11/15/2021 | 460.75% | Craig-Hallum | → $6 | Initiates Coverage On | → Buy |
What is the target price for NeuroOne Medical Tech (NMTC)?
The latest price target for NeuroOne Medical Tech (NASDAQ: NMTC) was reported by Alliance Global Partners on August 15, 2023. The analyst firm set a price target for $2.20 expecting NMTC to rise to within 12 months (a possible 105.61% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NeuroOne Medical Tech (NMTC)?
The latest analyst rating for NeuroOne Medical Tech (NASDAQ: NMTC) was provided by Alliance Global Partners, and NeuroOne Medical Tech maintained their buy rating.
When is the next analyst rating going to be posted or updated for NeuroOne Medical Tech (NMTC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeuroOne Medical Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeuroOne Medical Tech was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
Is the Analyst Rating NeuroOne Medical Tech (NMTC) correct?
While ratings are subjective and will change, the latest NeuroOne Medical Tech (NMTC) rating was a maintained with a price target of $3.25 to $2.20. The current price NeuroOne Medical Tech (NMTC) is trading at is $1.07, which is out of the analyst's predicted range.